| Literature DB >> 7963713 |
B S Bender1, W E Bell, S Taylor, P A Small.
Abstract
Mice transgenic for beta 2-microglobulin deletion (beta 2M-/-) were immunized intranasally with either a recombinant vaccinia virus that expressed both nucleoprotein and interleukin-2 or by infection with H3N2 influenza virus; 3-4 weeks later they were challenged with H1N1 influenza virus. The immunized beta 2M-/- mice had increased survival and enhanced clearance of virus relative to nonimmune controls. This protection correlated with the development of class II major histocompatibility complex-restricted pulmonary cytotoxic T lymphocyte activity and nasal IgA anti-nucleoprotein antibody. Heterotypic immunity can therefore be generated by a mechanism that does not involve class I major histocompatibility complex-restricted T cells.Entities:
Mesh:
Substances:
Year: 1994 PMID: 7963713 DOI: 10.1093/infdis/170.5.1195
Source DB: PubMed Journal: J Infect Dis ISSN: 0022-1899 Impact factor: 5.226